In The News: Department of Brain Health

The 51ԹϺ Department of Brain Health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients suffering from Alzheimer’s, dementia and other brain and neurological diseases. The center is the latest in a series of milestones from the department and the School of Integrated Health Sciences to better understand how a healthy brain functions, to improve care and treatment of people with brain diseases, and to identify mechanisms of brain disorders.
The University of Nevada, Las Vegas has announced a $6 million commitment from Joy Chambers-Grundy and the late Reg Grundy to establish a center dedicated to research on and the treatment of neurological disorders.
The University of Nevada, Las Vegas has announced a $6 million commitment from Joy Chambers-Grundy and the late Reg Grundy to establish a center dedicated to research on and the treatment of neurological disorders.

51ԹϺ announced Monday that it has launched a center dedicated to scientific research about brain and neurological diseases such as Alzheimer’s and dementia.

51ԹϺ announced Monday that it has launched a center dedicated to scientific research about brain and neurological diseases such as Alzheimer’s and dementia.

The 51ԹϺ department of brain health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients who are suffering from Alzheimer’s, dementia and other brain and neurological diseases.

The 51ԹϺ department of brain health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients who are suffering from Alzheimer’s, dementia and other brain and neurological diseases.

The 51ԹϺ department of brain health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients who are suffering from Alzheimer’s, dementia and other brain and neurological diseases.

An experimental drug could help caregivers as well as patients, as it substantially improved agitation in Alzheimer's patients in a late-stage clinical trial. The announcement boosted the shares of the maker of the treatment, Axsome Therapeutics (AXSM), nearly 25% to more than $95.

The Pentagon disclosed on Friday that 34 U.S. service members suffered traumatic brain injuries in Iran’s missile strike this month on an Iraqi air base, and although half have returned to work, the casualty total belies President Donald Trump’s initial claim that no Americans were harmed. He later characterized the injuries as “not very serious.”

The Pentagon disclosed on Friday that 34 U.S. service members suffered traumatic brain injuries in Iran's missile strike this month on an Iraqi air base, and although half have returned to work, the casualty total belies President Donald Trump's initial claim that no Americans were harmed. He later characterized the injuries as “not very serious.”

The Pentagon disclosed on Friday that 34 U.S. service members suffered traumatic brain injuries in Iran's missile strike this month on an Iraqi air base, and although half have returned to work, the casualty total belies President Donald Trump's initial claim that no Americans were harmed. He later characterized the injuries as “not very serious.”